❌

Normal view

  • ✇MIT Technology Review
  • The Download: the US digital rights crackdown, and AI companionship Charlotte Jee
    This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What it’s like to be banned from the US for fighting online hate   Just before Christmas the Trump administration dramatically escalated its war on digital rights by banning five people from entering the US. One of them, Josephine Ballon, is a director of HateAid, a small German nonprofit founded to support the victims of online harassment and violence.
     

The Download: the US digital rights crackdown, and AI companionship

19 January 2026 at 21:39

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

What it’s like to be banned from the US for fighting online hate  

Just before Christmas the Trump administration dramatically escalated its war on digital rights by banning five people from entering the US. One of them, Josephine Ballon, is a director of HateAid, a small German nonprofit founded to support the victims of online harassment and violence. The organization is a strong advocate of EU tech regulations, and so finds itself attacked in campaigns from right-wing politicians and provocateurs who claim that it engages in censorship. 

EU officials, freedom of speech experts, and the five people targeted all flatly reject these accusations. Ballon told us that their work is fundamentally about making people feel safer online. But their experiences over the past few weeks show just how politicized and besieged their work in online safety has become. Read the full story. 

—Eileen Guo

TR10: AI companions

Chatbots are skilled at crafting sophisticated dialogue and mimicking empathetic behavior. They never get tired of chatting. It’s no wonder, then, that so many people now use them for companionship—forging friendships or even romantic relationships. 

72% of US teenagers have used AI for companionship, according to a study from the nonprofit Common Sense Media. But while chatbots can provide much-needed emotional support and guidance for some people, they can exacerbate underlying problems in others—especially vulnerable people or those with mental health issues. 

Although some early attempts to regulate this space are underway, AI companionship is going nowhere. Read why we made it one of our 10 Breakthrough Technologies this year, and check out the rest of the list.

And, if you want to learn more about what we predict for AI this year, sign up to join me for our free LinkedIn Live event tomorrow at 12.30pm ET.

Why inventing new emotions feels so good  

Have you ever felt “velvetmist”?  

It’s a “complex and subtle emotion that elicits feelings of comfort, serenity, and a gentle sense of floating.” It’s peaceful, but more ephemeral and intangible than contentment. It might be evoked by the sight of a sunset or a moody, low-key album.  

If you haven’t ever felt this sensation—or even heard of it—that’s not surprising. A Reddit user generated it with ChatGPT, along with advice on how to evoke the feeling. Don’t scoff: Researchers say more and more terms for these “neo-­emotions” are showing up online, describing new dimensions and aspects of feeling. Read our story to learn more about why. 

—Anya Kamenetz

This story is from the latest print issue of MIT Technology Review. If you haven’t already, subscribe now to receive the next edition as soon as it lands (and benefit from some hefty seasonal discounts too!)

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 Ads are coming to ChatGPT 
For American users initially, with plans to expand soon. (CNN)
+ Here’s how they’ll work. (Wired $)

2 What will we be able to salvage after the AI bubble bursts? 
It will be ugly, but there are plenty of good uses for AI that we’ll want to keep. (The Guardian) 
+ What even is the AI bubble? (MIT Technology Review)

3 It’s almost impossible to mine Greenland’s natural resources 
It has vast supplies of rare earth elements, but its harsh climate and environment make them very hard to access. (The Week)

4 Iran is now 10 days into its internet shutdown
It’s one of the longest and most extreme we’ve ever witnessed. (BBC)
+  Starlink isn’t proving as helpful as hoped as the regime finds ways to jam it. (Reuters $)
+ Battles are raging online about what’s really going on inside Iran. (NYT $)

5 America is heading for a polymarket disaster 
Prediction markets are getting out of control, and some people are losing a lot of money. (The Atlantic $)
+ They were first embraced by political junkies, but now they’re everywhere. (NYT $)

6 How to fireproof a city 
Californians are starting to fight fires before they can even start. (The Verge $)
+ How AI can help spot wildfires. (MIT Technology Review)

7 Stoking ‘deep state’ conspiracy theories can be dangerous 
Especially if you’re then given the task of helping run one of those state institutions, as Dan Bongino is now learning. (WP $)
+ Why everything is a conspiracy now. (MIT Technology Review)

8 Why we’re suddenly all having a ‘Very Chinese Time’ 🇨🇳
It’s a fun, flippant trend—but it also shows how China’s soft power is growing around the globe. (Wired $) 

9 Why there’s no one best way to store information
Each one involves trade-offs between space and time. (Quanta $)

10 Meat may play a surprising role in helping people reach 100
Perhaps because it can assist with building stronger muscles and bones. (New Scientist $)

Quote of the day

“That’s the level of anxiety now – people watching the skies and the seas themselves because they don’t know what else to do.”

—A Greenlander tells The Guardian just how seriously she and her fellow compatriots are taking Trump’s threat to invade their country. 

One more thing

three silhouetted people in a boat crossing the water in the dark toward a beam of light
KATHERINE LAM

Inside a romance scam compound—and how people get tricked into being there

Gavesh’s journey started, seemingly innocently, with a job ad on Facebook promising work he desperately needed.

Instead, he found himself trafficked into a business commonly known as “pig butchering”—a form of fraud in which scammers form close relationships with targets online and extract money from them. The Chinese crime syndicates behind the scams have netted billions of dollars, and they have used violence and coercion to force their workers, many of them trafficked like Gavesh, to carry out the frauds from large compounds, several of which operate openly in the quasi-lawless borderlands of Myanmar.

Big Tech may hold the key to breaking up the scam syndicates—if these companies can be persuaded or compelled to act. Read the full story.

—Peter Guest & Emily Fishbein

We can still have nice things

A place for comfort, fun and distraction to brighten up your day. (Got any ideas? Drop me a line or skeet ’em at me.)

+ Blue Monday isn’t real (but it is an absolute banger of a track.) 
+ Some great advice here about how to be productive during the working day.
+ Twelfth Night is one of Shakespeare’s most fun plays—as these top actors can attest. 
+ If the cold and dark gets to you, try making yourself a delicious bowl of soup. 

LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management

npj Digital Medicine, Published online: 19 January 2026; doi:10.1038/s41746-026-02362-6

LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management

UroFusion-X: a unified multimodal deep learning framework for robust diagnosis, subtyping, and prognosis of urological cancers

npj Digital Medicine, Published online: 19 January 2026; doi:10.1038/s41746-025-02295-6

UroFusion-X: a unified multimodal deep learning framework for robust diagnosis, subtyping, and prognosis of urological cancers

Placebo effect influences vaccine responses

19 January 2026 at 08:00

Nature Medicine, Published online: 19 January 2026; doi:10.1038/s41591-025-04168-7

A randomized trial provides direct human evidence that the placebo effect can shape humoral immunity, showing that reward-related brain activity correlates with vaccine-induced antibody production and opening new avenues for treating many medical conditions.

Japanese AI Agent System on Human Papillomavirus Vaccination: System Design

arXiv:2601.10718v1 Announce Type: new Abstract: Human papillomavirus (HPV) vaccine hesitancy poses significant public health challenges, particularly in Japan where proactive vaccination recommendations were suspended from 2013 to 2021. The resulting information gap is exacerbated by misinformation on social media, and traditional ways cannot simultaneously address individual queries while monitoring population-level discourse. This study aimed to develop a dual-purpose AI agent system that provides verified HPV vaccine information through a conversational interface while generating analytical reports for medical institutions based on user interactions and social media. We implemented a system comprising: a vector database integrating academic papers, government sources, news media, and social media; a Retrieval-Augmented Generation chatbot using ReAct agent architecture with multi-tool orchestration across five knowledge sources; and an automated report generation system with modules for news analysis, research synthesis, social media sentiment analysis, and user interaction pattern identification. Performance was assessed using a 0-5 scoring scale. For single-turn evaluation, the chatbot achieved mean scores of 4.83 for relevance, 4.89 for routing, 4.50 for reference quality, 4.90 for correctness, and 4.88 for professional identity (overall 4.80). Multi-turn evaluation yielded higher scores: context retention 4.94, topic coherence 5.00, and overall 4.98. The report generation system achieved completeness 4.00-5.00, correctness 4.00-5.00, and helpfulness 3.67-5.00, with reference validity 5.00 across all periods. This study demonstrates the feasibility of an integrated AI agent system for bidirectional HPV vaccine communication. The architecture enables verified information delivery with source attribution while providing systematic public discourse analysis, with a transferable framework for adaptation to other medical contexts.

AnyECG: Evolved ECG Foundation Model for Holistic Health Profiling

arXiv:2601.10748v1 Announce Type: cross Abstract: Background: Artificial intelligence enabled electrocardiography (AI-ECG) has demonstrated the ability to detect diverse pathologies, but most existing models focus on single disease identification, neglecting comorbidities and future risk prediction. Although ECGFounder expanded cardiac disease coverage, a holistic health profiling model remains needed. Methods: We constructed a large multicenter dataset comprising 13.3 million ECGs from 2.98 million patients. Using transfer learning, ECGFounder was fine-tuned to develop AnyECG, a foundation model for holistic health profiling. Performance was evaluated using external validation cohorts and a 10-year longitudinal cohort for current diagnosis, future risk prediction, and comorbidity identification. Results: AnyECG demonstrated systemic predictive capability across 1172 conditions, achieving an AUROC greater than 0.7 for 306 diseases. The model revealed novel disease associations, robust comorbidity patterns, and future disease risks. Representative examples included high diagnostic performance for hyperparathyroidism (AUROC 0.941), type 2 diabetes (0.803), Crohn disease (0.817), lymphoid leukemia (0.856), and chronic obstructive pulmonary disease (0.773). Conclusion: The AnyECG foundation model provides substantial evidence that AI-ECG can serve as a systemic tool for concurrent disease detection and long-term risk prediction.

Multi-Stage Patient Role-Playing Framework for Realistic Clinical Interactions

arXiv:2601.10951v1 Announce Type: cross Abstract: The simulation of realistic clinical interactions plays a pivotal role in advancing clinical Large Language Models (LLMs) and supporting medical diagnostic education. Existing approaches and benchmarks rely on generic or LLM-generated dialogue data, which limits the authenticity and diversity of doctor-patient interactions. In this work, we propose the first Chinese patient simulation dataset (Ch-PatientSim), constructed from realistic clinical interaction scenarios to comprehensively evaluate the performance of models in emulating patient behavior. Patients are simulated based on a five-dimensional persona structure. To address issues of the persona class imbalance, a portion of the dataset is augmented using few-shot generation, followed by manual verification. We evaluate various state-of-the-art LLMs and find that most produce overly formal responses that lack individual personality. To address this limitation, we propose a training-free Multi-Stage Patient Role-Playing (MSPRP) framework, which decomposes interactions into three stages to ensure both personalization and realism in model responses. Experimental results demonstrate that our approach significantly improves model performance across multiple dimensions of patient simulation.

MetaboNet: The Largest Publicly Available Consolidated Dataset for Type 1 Diabetes Management

arXiv:2601.11505v1 Announce Type: cross Abstract: Progress in Type 1 Diabetes (T1D) algorithm development is limited by the fragmentation and lack of standardization across existing T1D management datasets. Current datasets differ substantially in structure and are time-consuming to access and process, which impedes data integration and reduces the comparability and generalizability of algorithmic developments. This work aims to establish a unified and accessible data resource for T1D algorithm development. Multiple publicly available T1D datasets were consolidated into a unified resource, termed the MetaboNet dataset. Inclusion required the availability of both continuous glucose monitoring (CGM) data and corresponding insulin pump dosing records. Additionally, auxiliary information such as reported carbohydrate intake and physical activity was retained when present. The MetaboNet dataset comprises 3135 subjects and 1228 patient-years of overlapping CGM and insulin data, making it substantially larger than existing standalone benchmark datasets. The resource is distributed as a fully public subset available for immediate download at https://metabo-net.org/ , and with a Data Use Agreement (DUA)-restricted subset accessible through their respective application processes. For the datasets in the latter subset, processing pipelines are provided to automatically convert the data into the standardized MetaboNet format. A consolidated public dataset for T1D research is presented, and the access pathways for both its unrestricted and DUA-governed components are described. The resulting dataset covers a broad range of glycemic profiles and demographics and thus can yield more generalizable algorithmic performance than individual datasets.
  • ✇Latest Science News -- ScienceDaily
  • AI maps the hidden forces shaping cancer survival worldwide
    Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ so dramatically around the world. By analyzing cancer data and health system information from 185 countries, the AI model highlights which factors, such as access to radiotherapy, universal health coverage, and economic strength, are most closely linked to better survival in each nation.
     

AI maps the hidden forces shaping cancer survival worldwide

17 January 2026 at 22:26
Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ so dramatically around the world. By analyzing cancer data and health system information from 185 countries, the AI model highlights which factors, such as access to radiotherapy, universal health coverage, and economic strength, are most closely linked to better survival in each nation.

Wearable device derived electrocardiographic age and its association with atrial fibrillation

npj Digital Medicine, Published online: 17 January 2026; doi:10.1038/s41746-026-02344-8

Wearable device derived electrocardiographic age and its association with atrial fibrillation

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

17 January 2026 at 04:14
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
  • ✇TechCrunch
  • The AI healthcare gold rush is here Theresa Loconsolo
    AI companies are clustering around healthcare and fast.  In just the past week, OpenAI bought health startup Torch, Anthropic launched Claude for healthcare, and Sam Altman-backed MergeLabs closed a $250 million seed round at an $850 million valuation. The money and products are pouring into health and voice AI, but so are concerns about hallucination risks, inaccurate medical information, and […]
     

The AI healthcare gold rush is here

17 January 2026 at 02:57
AI companies are clustering around healthcare and fast.  In just the past week, OpenAI bought health startup Torch, Anthropic launched Claude for healthcare, and Sam Altman-backed MergeLabs closed a $250 million seed round at an $850 million valuation. The money and products are pouring into health and voice AI, but so are concerns about hallucination risks, inaccurate medical information, and […]
  • ✇STAT
  • STAT+: JPM Week 2026 is over. It was fantastic. Here’s why Adam Feuerstein
    This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. A chill week No M&A. Some news but not a deluge. The weather was amazing. I took a walk in Golden Gate Park and came across the sculpture above, whatever it is.  The entire week was, dare I say it, chill. Just the way I wanted it to be. Continue to STAT+ to read the full story…
     

STAT+: JPM Week 2026 is over. It was fantastic. Here’s why

16 January 2026 at 19:30

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

A chill week

No M&A. Some news but not a deluge. The weather was amazing. I took a walk in Golden Gate Park and came across the sculpture above, whatever it is. 

The entire week was, dare I say it, chill. Just the way I wanted it to be. 

Continue to STAT+ to read the full story…

© Josh Edelson/AFP/Getty Images

Cellular neighborhoods in cancer

Nat Cancer. 2026 Jan 16. doi: 10.1038/s43018-025-01107-w. Online ahead of print.

ABSTRACT

The concept of cellular neighborhoods, defined as recurring structures within the tissue with characteristic cell compositions and interactions, has transformed our understanding of the complexity and dynamics of tumor ecosystems. Recent advances in spatial omics and computational modeling have enabled high-resolution mapping of these neighborhoods, providing unprecedented insights into their roles in shaping tumor heterogeneity, evolution and therapeutic responses. Despite these advances, a unified framework for interpreting cellular neighborhoods remains lacking. This Perspective synthesizes emerging concepts and insights, focusing on the definition and classification of cellular neighborhoods in cancer, computational methods for identifying and comparing them, and their clinical relevance.

PMID:41545713 | DOI:10.1038/s43018-025-01107-w

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy

Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04073-z

Analyses of liver biopsies from a child with spinal muscular atrophy treated with adeno-associated virus gene therapy who developed hepatitis reveal contaminating manufacturing plasmids and disrupted vector genomes, possibly resulting from recombination events.

Clinical proteomics in cardiovascular medicine: Current capabilities, limitations, and future directions

Atherosclerosis. 2026 Jan 8;413:120637. doi: 10.1016/j.atherosclerosis.2026.120637. Online ahead of print.

ABSTRACT

BACKGROUND AND AIMS: Commercial high-throughput proteomics platforms, such as Olink and SomaLogic, enable large-scale epidemiological studies with integrated multi-omics measurements. While these proteomics approaches have been widely applied in biobanks, issues of data quality remain underappreciated. In this review, we discuss these limitations and outline a way forward for realizing the clinical translation of proteomics as a comprehensive 'liquid health check'.

METHODS: We reviewed the recent literature for artificial intelligence (AI) and multi-omics, particularly proteomics in atherosclerotic cardiovascular disease (ASCVD).

RESULTS: AI-driven multi-omics analyses have the potential to advance our understanding of multifactorial causes of ASCVD, including aging. Emerging concepts such as "ageotypes" suggest the potential for personalized intervention to slow aging processes. Commercial proteomics platforms have accelerated biomarker discovery in ASCVD, but challenges remain in clinical translation. Limited correlation between Olink and SomaLogic necessitates orthogonal validation of findings. Platform-specific issues, such as epitope effects and cross-reactivity, can yield divergent protein quantitative trait loci for the same protein, complicating causal inference. While tissue proteomics provides complementary insights to plasma proteomics, reliance on autopsy samples raises concerns about protein degradation and measurement reliability. Increasingly, single-cell and spatial proteomics are being explored to better capture plaque heterogeneity, complementing bulk proteomics in larger cohorts.

CONCLUSION: Beyond risk prediction, proteomics offers opportunities to elucidate disease mechanisms and enable drug repurposing. To realize the clinical potential of plasma proteomics, absolute or reliably recalibratable relative quantification will be required to guide patient care. Ultimately, the clinical value of proteomics will be determined by the quality rather than the quantity of protein measurements.

PMID:41539063 | DOI:10.1016/j.atherosclerosis.2026.120637

❌